AG
ZSAN

Advisor Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Advisor Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
31
– – ﹤0.01% 5052
2019
Q3 		$2K Hold
31
– – ﹤0.01% 5036
2019
Q2 		$4K Hold
31
– – ﹤0.01% 4809
2019
Q1 		$5K Buy
+31
New +$3.8K ﹤0.01% 4723

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group's ZSAN Position: Q4 2019 in Review

Advisor Group held its Zosano Pharma Corporation (ZSAN) position steady in Q4 2019 at 31 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5052.

Advisor Group first reported a position in ZSAN in Q1 2019 and has held it in 4 quarters since. The position peaked at $5K in Q1 2019. 29 funds tracked by Wall St. Rank hold ZSAN as of Q4 2019.

  • Advisor Group held 31 shares of Zosano Pharma Corporation worth $2K as of Q4 2019.
  • Advisor Group left its Zosano Pharma Corporation share count unchanged in Q4 2019.
  • Zosano Pharma Corporation made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5052 holding.
  • Advisor Group first reported a position in Zosano Pharma Corporation in Q1 2019 and has held it in 4 quarters since.
  • Advisor Group's Zosano Pharma Corporation position peaked at $5K in Q1 2019.
  • 29 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.